Bio Green Med Solution (BGMS) Net Equity Issued and Repurchased (2010 - 2026)
Bio Green Med Solution (BGMS) posted quarterly Net Equity Issued and Repurchased of $125000.0 for Q1 2026, down 96.79% year-over-year from $3.9 million in Q1 2025, and down 85.48% quarter-over-quarter from $861000.0 in Q4 2025.
Powered by 
Analysis
Bio Green Med Solution (BGMS) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends
Bio Green Med Solution (BGMS) has reported Net Equity Issued and Repurchased for 15 consecutive years, with $125000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Equity Issued and Repurchased fell 96.79% year-over-year to $125000.0; the TTM figure through Mar 2026 stood at $2.7 million (down 45.72% YoY), while the FY2025 annual figure was $6.4 million, up 3.48% from the prior year.
- Net Equity Issued and Repurchased declined to $125000.0 in Q1 2026 per BGMS's latest filing, from $861000.0 in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $3.9 million in Q1 2025 and bottomed at -$3000.0 in Q3 2025.
- Historically, Net Equity Issued and Repurchased has averaged $1.1 million across 3 years, with a median of $493000.0 in 2025.
- Annual changes were most pronounced in 2025 — Net Equity Issued and Repurchased plunged 200.0% — and 2026, when it sank 96.79%.
- Bio Green Med Solution's Net Equity Issued and Repurchased stood at -$1000.0 in 2024, then jumped by 86200.0% to $861000.0 in 2025, then plunged by 85.48% to $125000.0 in 2026.
- Business Quant data shows BGMS's Net Equity Issued and Repurchased at $125000.0 in Q1 2026, $861000.0 in Q4 2025, and -$3000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.50 Bn | 133.65 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.53 Bn | 78.54 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 65.05 Bn | 59.86 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.11 Bn | 51.98 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.71 Bn | 44.71 Bn | - | 141.90 Mn |
| 6 | BeOne Medicines | 40.40 Bn | 35.31 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.36 Bn | 32.05 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.16 Bn | 27.32 Bn | - | - |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | - |
| 10 | Bio Green Med Solution | 4.87 Mn | 1.08 Mn | 79,000.00 | 794,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 794,000.00 |
| Mar 31, 2026 | 125,000.00 |
| Dec 31, 2025 | 861,000.00 |
| Sep 30, 2025 | -3,000.00 |
| Jun 30, 2025 | 1.67 Mn |
| Mar 31, 2025 | 3.89 Mn |
| Sep 30, 2024 | -1,000.00 |
| Dec 31, 2021 | 1.00 Mn |
| Sep 30, 2021 | 3.00 Mn |
| Dec 31, 2020 | 11.40 Mn |
| Sep 30, 2019 | -7,000.00 |
| Jun 30, 2019 | 4.70 Mn |
| Mar 31, 2019 | 4.11 Mn |
| Dec 31, 2018 | 700,000.00 |
| Dec 31, 2017 | -2,000.00 |
| Sep 30, 2017 | 13.69 Mn |
| Mar 31, 2017 | 86,000.00 |
| Dec 31, 2016 | 1.55 Mn |
| Mar 31, 2016 | 500,000.00 |
| Dec 31, 2015 | 485,000.00 |